Bottle Label 5 mg (71610 0503 60)
Terazosin Capsule
Product Images NDC 71610-503
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 71610-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Bottle Label 2 mg (71610 0510 30)
Aphena Pharma Solutions (TN)
Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)
Figure 1 (Terazosin Hydrochloride Capsules 2)
Figure 2 (Terazosin Hydrochloride Capsules 3)
The provided text is a tabular format indicating the mean change from the baseline for different time intervals of 7 months, starting from month 0 to month 30, at an interval of 3 months.*
Figure 3 (Terazosin Hydrochloride Capsules 4)
Data appears to be a chart or graph with measurements in mL/sec taken over a period of time from Month 0 to Month 30. Without additional context or labels, it is difficult to determine the exact nature or significance of the data.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
